company background image
CNGG.F

Cann Group OTCPK:CNGG.F Stock Report

Last Price

US$0.12

Market Cap

US$43.2m

7D

0%

1Y

-51.9%

Updated

29 May, 2023

Data

Company Financials

CNGG.F Stock Overview

Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets.

CNGG.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Cann Group Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cann Group
Historical stock prices
Current Share PriceAU$0.12
52 Week HighAU$0.23
52 Week LowAU$0.086
Beta1.13
1 Month Change11.41%
3 Month Changen/a
1 Year Change-51.93%
3 Year Change-85.34%
5 Year Change-94.91%
Change since IPO-95.08%

Recent News & Updates

Recent updates

Shareholder Returns

CNGG.FUS PharmaceuticalsUS Market
7D0%-2.7%0.06%
1Y-51.9%-4.9%-0.7%

Return vs Industry: CNGG.F underperformed the US Pharmaceuticals industry which returned -4.9% over the past year.

Return vs Market: CNGG.F underperformed the US Market which returned -0.7% over the past year.

Price Volatility

Is CNGG.F's price volatile compared to industry and market?
CNGG.F volatility
CNGG.F Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement10.6%
Market Average Movement6.5%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.0%

Stable Share Price: Insufficient data to determine CNGG.F's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine CNGG.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2014n/aPeter Koetsierhttps://www.canngrouplimited.com

Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.

Cann Group Limited Fundamentals Summary

How do Cann Group's earnings and revenue compare to its market cap?
CNGG.F fundamental statistics
Market CapUS$43.22m
Earnings (TTM)-US$24.23m
Revenue (TTM)US$9.42m

4.5x

P/S Ratio

-1.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CNGG.F income statement (TTM)
RevenueAU$14.40m
Cost of RevenueAU$0
Gross ProfitAU$14.40m
Other ExpensesAU$51.43m
Earnings-AU$37.03m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.095
Gross Margin100.00%
Net Profit Margin-257.18%
Debt/Equity Ratio78.2%

How did CNGG.F perform over the long term?

See historical performance and comparison